| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debashis Dutta Appointed as Managing Director since October 2021 | Managing Director | 01-Oct-2021 | Current |
Amitava Ghosh Appointed as Whole-time director since February 2026 | Whole-time director | 02-Feb-2026 | Current |
Mahashweta Dutta Appointed as Whole-time director since September 1998 | Whole-time director | 01-Sep-1998 | Current |
Pratik Mukherjee Appointed as Whole-time director since August 2019 | Whole-time director | 06-Aug-2019 | Current |
Saumitra Pal Appointed as Whole-time director since May 2014 | Whole-time director | 01-May-2014 | Current |
Suman Bagchi Appointed as Whole-time director since July 2024 | Whole-time director | 01-Jul-2024 | Current |
Tushar Kar Appointed as Whole-time director since March 2023 | Whole-time director | 16-Mar-2023 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for G.D. Pharmaceuticals Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in G.D. Pharmaceuticals Private Limited's leadership journey.
Loading...
Contact Details
- Address 94, Nalini Ranjan Avenue,, Kolkata West Bengal, 700053, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 700053
- Country India
- Website boroline.com
Frequently Asked Questions
You can contact G.D. Pharmaceuticals Private Limited through their registered address at 94, Nalini Ranjan Avenue,, Kolkata West Bengal, 700053, India, or via their website at boroline.com. Social media links are also provided where applicable.
The current directors of G.D. Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- PRATIK MUKHERJEE
- DEBASHIS DUTTA
- Suman Bagchi
- MAHASHWETA DUTTA
- TUSHAR KAR
- SAUMITRA PAL
- Amitava Ghosh
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.